Sigal Blau is an accomplished professional in the pharmaceutical industry, currently serving as the Head of the R&D CMC department at Dexcel Pharma since September 2017. With a robust background in generic R&D, Sigal Blau held various roles at Teva Pharmaceutical Industries Ltd. from August 2000 to 2002, including Formulator, Team Leader, and Project Manager. Prior experience also includes leading the R&D department at CTS Ltd. from February 2013 to August 2017. Sigal Blau earned a Ph.D. in Pharmaceutical Sciences from The Hebrew University, completing the program in 2000.
This person is not in any teams
This person is not in any offices